Yahoo Finance 
Global Omega-3 Ingredients Market Report 2022-2027: Rising Prevalence of Certain Diseases has Increased the Demand for Omega-3-ingredient Products.
Global Omega-3 Ingredients Market
Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Omega-3 Ingredients Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.
The rising prevalence of cardiovascular disease and cancer across the globe is expected to drive the omega-3 ingredient market during the forecast period.
Moreover, rising awareness about healthcare measures among consumers is expected to be a major growth driver for the overall market. Rising consumer spending on complementary health approaches is anticipated to drive the growth of the omega-3 ingredient market.
According to the national centre for complementary and integrative health, it is estimated that around 59 million Americans spend money on complementary health approaches, and their total spending adds up to $30.2 billion a year.
Market Trends
The growing popularity of certified food ingredients coupled with a concern for health and wellness to maintain proper health is creating more demand for omega-3 ingredients. Increasing investments in research and development activities by food and beverage manufacturers and rising advancements in technology are boosting the omega-3 ingredient market's growth. Furthermore, EPA and DHA have been gaining popularity in the market and are becoming - part of the consumer's daily diet.
Growth Factor
The rising prevalence of certain diseases has increased the demand for omega-3-ingredient products.
A rise in the geriatric population and a high prevalence of cardiovascular diseases is expected to propel market growth. According to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death globally, claiming an estimated 17.9 million lives each year.
More than four out of five CVD deaths are due to heart attacks and strokes, while one-third of these deaths occur prematurely in people under 70 years of age. These alarming statistics have drawn people's attention to their health and dietary habits. Consumers are spending more on their dietary supplements and including omega-3 ingredients in their diets to develop strong immunity and support heart and brain health, which is expected to boost the demand for omega-3 ingredient products in the coming years.
Furthermore, rising cases of obesity and diabetes are expected to increase the demand for DHA. An unhealthy diet, physical inactivity, tobacco use, and harmful alcohol use are all risk factors for heart disease and stroke. These risk factors are showing a growing trend in the current population.
Obesity and diabetes are other agitating reasons for heart disease. Diabetes affected approximately 463 million adults aged 20-79 in 2019 (Source: International Diabetes Federation). This has led to the growth of the omega-3 ingredient market. BASF nutrition and health has partnered with Ideogen for the introduction of the omega-3 fatty acid solution 'hepacor' to Europe. This food contains a concentrated amount of EPA and DHA that will help to treat fatty liver disease. lant-based Multi Omega 3-6-9 gummies and soft gels from Forest Remedies. The Impact of COVID-19 on the Omega-3 Ingredients Market
The market for omega-3 ingredients is expected to grow positively because of the COVID-19 outbreak. As the number of people infected with the COVID-19 virus grows, the demand for healthy food products has increased worldwide. The consumption of a nutrition-rich diet has increased during the pandemic to keep overall health on track, which has increased the demand for omega-3 ingredients in the market.
Competitive Insights
The rising prevalence of various diseases across the globe has led to the entry of several new players in the omega-3 ingredient market. To increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and the development of novel solutions, which are expected to keep the market competitive and constantly evolving.
Major market players like BASF SE and DSM, among others, have been covered along with their relative competitive strategies. The report also mentions recent deals and investments by different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered, along with the recent deals and investments of these important players in the omega-3 ingredients market.
Key Topics Covered:
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
5. Omega-3 Ingredients Market by Type
5.1. Eicosapentaenoic acid (EPA)
5.2. Docosahexaenoic acid (DHA)
5.3. Alpha-linolenic acid (ALA)
6. Omega-3 Ingredients Market by source
6.1. Marine oils
6.2. Plant oils
7. Omega-3 Ingredients Market by Application
7.1. Pharmaceuticals
7.2. Pet and Animal Feed
7.3. Supplements and Functional foods
7.4. Infant Formulas
7.5. Others
8. Omega-3 Ingredients Market by Geography
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Thailand
8.5.6. Indonesia
8.5.7. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. Reckitt Benckiser Group plc
10.2. Unilever Life
10.3. Abbott Laboratories
10.4. Amway Corp
10.5. Sanofi S.A.
10.6. GlaxoSmithKline plc
10.7. The Nature's Bounty Co.
10.8. Omega Natural Science, Inc.
10.9. Bionova
10.10. Arkopharma
10.11. Blackmores
10.12. KD Pharma Group
For more information about this report visit https://www.researchandmarkets.com/r/ku3wzk
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
